HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy

被引：0
|
作者：
Zhao, Jing [1 ]
Zhang, Chao [2 ]
Suo, Aili [3 ]
Shi, Qiuying [4 ]
Wei, Zhimin [1 ]
Li, Zaibo [5 ]
Krishnamurti, Uma [6 ]
Li, Xiaoxian [6 ]
机构：
[1] Qingdao Univ, Affiliated Hosp, Qingdao, Shandong, Peoples R China
[2] Winship Canc Inst, Atlanta, GA USA
[3] Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China
[4] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
[5] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
[6] Emory Univ, Atlanta, GA 30322 USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
291
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer
    Yang, Zheng-Jun
    Xin, Fei
    Chen, Zu-Jin
    Yu, Yue
    Wang, Xin
    Cao, Xu-Chen
    BMC CANCER, 2024, 24 (01)
  • [32] Impact of the Change of the Criteria for HER2 Immunohistochemistry Interpretation on HER2 Status in Breast Cancer
    Harada, Shuko
    Shen, Dejun
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 44A - 44A
  • [33] Impact of the Change of the Criteria for HER2 Immunohistochemistry Interpretation on HER2 Status in Breast Cancer
    Harada, Shuko
    Shen, Dejun
    Wei, Shi
    LABORATORY INVESTIGATION, 2016, 96 : 44A - 44A
  • [34] Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer
    Guarneri, V.
    Barbieri, E.
    Dieci, M. V.
    Piacentini, F.
    Conte, P.
    CANCER TREATMENT REVIEWS, 2010, 36 : S62 - S66
  • [35] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [36] Next-generation sequencing based detection of HER2 copy number predicts pathological response to neoadjuvant therapy in HER2 positive breast cancer
    Dai, Hao
    Jiao, Dechuang
    Guo, Xuhui
    Qiao, Jianghua
    Li, Anfang
    Lu, Zhenduo
    Chen, Xiuchun
    Wang, Chengzheng
    Yan, Min
    Liu, Zhenzhen
    CANCER RESEARCH, 2024, 84 (06)
  • [37] Breast Cancer Biomarker Changes and Correlations with HER2 Change in ER Positive, HER2 Negative Breast Cancers Treated with Neoadjuvant Endocrine Therapy
    Huang, Wei
    Tyburski, Haley
    Finkelman, Brian
    Turner, Bradley
    Weiss, Anna
    Dhakal, Ajay
    Skinner, Kristin
    Hicks, David
    Zhang, Huina
    LABORATORY INVESTIGATION, 2024, 104 (03) : S175 - S176
  • [38] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Morsberger, Laura
    Pallavajjala, Aparna
    Long, Patty
    Hardy, Melanie
    Park, Rebecca
    Parish, Rebecca
    Nozari, Azin
    Zou, Ying S.
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [39] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Laura Morsberger
    Aparna Pallavajjala
    Patty Long
    Melanie Hardy
    Rebecca Park
    Rebecca Parish
    Azin Nozari
    Ying S. Zou
    Cancer Cell International, 22
  • [40] Optimal Regimen of Neoadjuvant Systemic Therapy for HER2 Positive Early Breast Cancer
    Lo, C.
    Wang, M. -Y.
    Kuo, W. -H.
    Lee, Y. -H.
    Tsai, L. -W.
    Lu, Y. -S.
    Lin, C. -H.
    Chang, D. -Y.
    Chen, W. -W.
    Huang, C. -S.
    BREAST, 2023, 68 : S61 - S62
12345